ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway

Li, Xiaoqi; Wang, Xin; Wang, Binyu; Chi, Weiqun; Li, Zhangyi; Zhang, Min; Shen, Yifu; Liu, Xu; Lu, Youmei; Liu, Yu*哈尔滨医科大学; y
PHYTOMEDICINE2022-5DOI: 10.1016/j.phymed.2022.154027
8被引15阅读
引用收藏
分享

摘要

Background: Doxorubicin (DOX) is a highly effective broad-spectrum antitumor agent, but its clinical administration is limited by self-induced cardiotoxicity. Dihydromyricetin (DHM) is a flavonoid compound extracted from the Japanese raisin tree. Evidence that DHM has neovascular protective properties makes it a candidate for studying cardiotoxicity prevention strategy. However, it remains unknown if DHM can protect against cardiotoxicity caused by DOX. Purpose: The present study was performed to evaluate the protective effect of DHM on DOX-induced cardiotoxicity in vivo and in vitro. Methods: C57BL/6 mice were intraperitoneally injected with DOX to construct cardiac injury model in vivo, and AC16 cells were exposed to DOX to induce cell injury in vitro. Left ventricular function of mice were detected by echocardiography, the apoptosis of mice cardiac tissue and AC16 cells were detected by TUNEL and Hoechst33342/PI double staining. The expression of apoptosis and autophagy related proteins were detected by western blotting, immunohistochemical staining and immunofluorescence staining. Results: Echocardiographic results showed that DOX-induced cardiotoxicity were significantly alleviated by DHM pretreatment. DOX induced cardiotoxicity of mice by inhibiting AMPK activation, increasing apoptosis and decreasing autophagy. However, under the same conditions, the heart tissue of DHM-pretreated mice showed increased autophagy and decreased apoptosis via activation AMPK/mTOR pathway. The same results were observed in vitro, and it was also found that DHM can inhibit the production of intracellular ROS in vitro. Conclusion: DHM protects against cardiotoxicity by inhibiting apoptosis and oxidative stress and it can allevate theautophagy inhibition caused by DOX through AMPK/mTOR pathway. DHM preconditioning may be a breakthrough in protecting DOX-induced cardiotoxicity in the future clinical applications.

学科与关键词

关键词
DihydromyricetinDoxorubicinCardiotoxicityAutophagyAMPK
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2022-05
卷期
第 99 卷
页码
154027
DOI
10.1016/j.phymed.2022.154027
语言
GERMAN
期刊等级
2区
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2017M620121]; Heilongjiang Postdoctoral Research Foun-dation [LBH-Z17223]

作者

  • L

    Li, Xiaoqi (第一作者)

    harbin med univ

  • W

    Wang, Xin

    harbin med univ

查看全部 10 位作者收起作者
  • W

    Wang, Binyu

    harbin med univ

  • C

    Chi, Weiqun

    harbin med univ

  • L

    Li, Zhangyi

  • Z

    Zhang, Min

    harbin med univ

  • S

    Shen, Yifu

    harbin med univ

  • L

    Liu, Xu

    harbin med univ

  • L

    Lu, Youmei

    harbin med univ

  • L

    Liu, Yu (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417